期刊文献+

分析乳腺非特殊型浸润性导管癌Luminal B-HER-2(-)型和Luminal B-HER-2(+)型乳腺断层摄影征象 被引量:2

The Analysis of the Imaging Signs of Digital Breast Tomosynthesis in Non-Specific Invasive Ductal of Breast Carcinoma Between Luminal B-HER-2(-) type and Luminal B-HER-2(+) type
原文传递
导出
摘要 目的探讨乳腺非特殊型浸润性导管癌Luminal B-HER-2(-)型和Luminal B-HER-2(+)型临床病理特征及影像征象。方法搜集行数字乳腺断层合成摄影(DBT)及全屏数字化乳腺X线摄影(FFDM),并手术病理证实Luminal B型浸润型导管癌364例,对影像征象进行统计分析。结果乳腺非特殊型浸润性导管癌Luminal B-HER-2(-)型和Luminal B-HER-2(+)型在肿块大小(χ^(2)=10.619,P=0.005)、肿块边缘(χ^(2)=11.663,P=0.003)、钙化分布(χ^(2)=38.023,P=0.000)、钙化形态(χ^(2)=10.792,P=0.013)差异有统计学意义(P值均<0.05)。结论初步区分非特殊型浸润性导管癌Luminal B-HER-2(-)型和Luminal B-HER-2(+)型的影像征象,为临床治疗提供诊断依据。 Objective To investigate the clinicopathological features and imaging signs of non-specific invasive ductal carcinoma of the breast between Luminal B-HER-2(-) type and Luminal B-her-2(+) type. Methods 364 cases of non-specific invasive ductal breast carcinoma were examined by full-field digital mammography(FFDM) and Digital breast tomosynthesis(DBT),and were confirmed by surgical pathology.The image signs were analyzed statistically. Results Luminal B-HER-2(-)type and Luminal B-HER-2(-) type were statistically differences in tumor size(χ^(2)=10.619,P=0.005)、tumor margin(χ^(2)=11.663,P=0.003)、calcium distribution(χ^(2)=38.023,P=0.000)and calcification morphology(χ^(2)=10.792,P=0.013)(All P<0.05). Conclusion the image signs of Luminal B-HER-2(-) and Luminal B-HER-2(+) types of non-specific invasive ductal carcinoma were preliminarily distinguished, which provide diagnostic basis for clinical treatment.
作者 张曦 马明瑞 明洁 马晓剑 李莉 汪湍 ZHANG Xi;MA Mingrui;Ming Jie(Tumor Subsidiary Hospital of Xinjiang Medical University,Urumqi,Xinjiang Province 830011,P.R.China)
出处 《临床放射学杂志》 北大核心 2021年第8期1491-1494,共4页 Journal of Clinical Radiology
基金 自治区卫生健康青年医学科技人才专项科研项目(编号:WJWY-201969)。
关键词 乳腺癌 病理组织学 数字乳腺断层合成摄影 影像征象 Breast carcinoma Histopathology Digital breast tomosynthesis Image signs
  • 相关文献

参考文献9

二级参考文献52

  • 1赵永霞,秦维昌.数字乳腺X线摄影的现状与进展[J].中华放射学杂志,2007,41(12):1421-1424. 被引量:21
  • 2Park S, Koo JS, Kim MS, et al. Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry [ J ]. Breast, 2012, 21 ( 1 ) : 50-57.
  • 3Fountzilas G, Dafni U, Bobos M, et al. Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel[J]. PIoS One, 2012, 7(6) : e37946.
  • 4E1 Fatemi H, Chahbouni S, Jayi S, et al. Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco[ J]. Diagn Pathol, 2012, 7 : 170.
  • 5Cintra JR, Teixeira MT, Diniz RW, et al. Immunohistochemical profile and clinical-pathological variables in breast cancer[ J]. Rev Assoe Med Bras,2012,58(2) :178-187.
  • 6Cheang MC, Chia SK, Voduc D, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer [ Jl. J Natl Cancer Inst, 2009, 101 (10) : 736-750.
  • 7Jinno H, Matsuda S, Hayashida T, et al. Differential pathological response to preoperative chemotherapy across breast cancer intrinsic subtypes [ J ]. Chemotherapy, 2012, 58 (5) : 364-370.
  • 8Mazouni C, Rimareix F, Mathieu MC, et al. Outcome in breast molecular subtypes according to nodal status and surgical procedures[J]. Am J Surg, 2013, 205(6) : 662-667.
  • 9Arvold ND, Taghian AG, Niemierko A, et al. Age, breast cancer subtype approximation, and local recurrence after breast- conserving therapy[J]. J Clin Oneol, 2011, 29(29) : 3885-3891.
  • 10Kneubil MC, Brollo J, Botteri E, et at. Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction [ J ]. Eur J Surg Oncol, 2013, 39 ( 3 ) : 260-265.

共引文献1269

同被引文献20

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部